Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Capricor Therapeutics (CAPR) Other Non-Current Assets (2016 - 2025)

Historic Other Non-Current Assets for Capricor Therapeutics (CAPR) over the last 17 years, with Q3 2025 value amounting to $488738.0.

  • Capricor Therapeutics' Other Non-Current Assets rose 5309.13% to $488738.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $488738.0, marking a year-over-year increase of 5309.13%. This contributed to the annual value of $221700.0 for FY2024, which is 1732.92% down from last year.
  • Per Capricor Therapeutics' latest filing, its Other Non-Current Assets stood at $488738.0 for Q3 2025, which was up 5309.13% from $508002.0 recorded in Q2 2025.
  • Over the past 5 years, Capricor Therapeutics' Other Non-Current Assets peaked at $508002.0 during Q2 2025, and registered a low of $88701.0 during Q1 2021.
  • Moreover, its 5-year median value for Other Non-Current Assets was $268172.0 (2022), whereas its average is $278899.5.
  • Examining YoY changes over the last 5 years, Capricor Therapeutics' Other Non-Current Assets showed a top increase of 22547.66% in 2021 and a maximum decrease of 1739.52% in 2021.
  • Over the past 5 years, Capricor Therapeutics' Other Non-Current Assets (Quarter) stood at $275722.0 in 2021, then fell by 2.74% to $268172.0 in 2022, then changed by 0.0% to $268172.0 in 2023, then dropped by 17.33% to $221700.0 in 2024, then surged by 120.45% to $488738.0 in 2025.
  • Its last three reported values are $488738.0 in Q3 2025, $508002.0 for Q2 2025, and $253374.0 during Q1 2025.